$3.22
+ $0.22 (7.33%)
End-of-day quote: 05/16/2024
NasdaqCM:HRTX

Heron Therapeutics Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$127.04M $107.67M $86.35M $88.64M $145.97M $77.47M $30.77M $1.28M $0.00M $0.00M $0.00M $0.00M $1.30M $1.26M $0.37M $0.41M $0.00M $5.39M $5.40M
GM % Gross Margin %
7.90% -46.91% -104.81% -136.38% -56.88% -116.26% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -91.04% 100.00%
OM Operating Margin
-73.21% -157.20% -252.27% -251.09% -144.34% -237.42% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -157.17% -172.39%
EPS Earnings Per Share
$0.00 $-0.80 $-1.67 $-2.24 $-2.50 $-2.50 $-2.44 $-3.65 $-4.56 $-2.95 $-2.87 $-3.42 $-2.00 $-4.88 $-6.20 $-14.80 $-23.00 $-56.80 $-26.40 $-32.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 -0.00% -0.00% -0.00% -0.00% -0.00% 0 0 0 0 0 0 0 0 0 0
Sha. Shares
150.29m 119.16m 102.01m 91.31m 90.3m 78.17m 64.61m 39.36m 36.11m 29.23m 23.57m 15.11m 1.99m 1.96m 1.54m 1.54m 0.32m 0.31m 0.31m
OCF Operating Cash Flow
$-58.79M $-146.91M $-203.35M $-184.82M $-124.58M $-191.81M $-170.30M $-134.10M $-78.53M $-60.28M $-40.76M $-17.01M $-5.48M $-11.00M $-24.28M $-17.28M $9.18M $-7.53M $-7.43M
FCF Free Cash Flow
$-106.55M $-148.74M $-206.38M $-191.63M $-131.73M $-200.98M $-172.85M $-137.23M $-79.61M $-61.72M $-53.87M $-17.98M $-5.56M $0.00M $-24.58M $-17.76M $8.99M $-7.85M $-7.62M
FCFS Free Cash Flow Per Share
$-0.44 $-1.37 $-2.10 $-2.11 $-1.61 $-2.75 $-3.20 $-3.62 $-2.41 $-2.32 $-2.63 $-1.47 $-2.80 $-6.74 $-15.95 $-18.35 $28.48 $-24.98 $-26.61